Economic aspects of allergies: Status and prospects for Austria;Volkswirtschaftliche aspekte von allergien. Ausgangslage und ausblick für Österreich

Wiener Medizinische Wochenschrift

Volumn 157, Issue 11-12, 2007, Pages 248-254

  Stein, Viktoria ^a   Dorner, Thomas ^a   Lawrence, Kitty ^a   Kunze, Michael ^a   Rieder, Anita ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy induced costs; Alternative and complementary medicine; Cost effectiveness; Health economics; Sick leave

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; HOMEOPATHIC AGENT; NOSE DROPS;

ALLERGY; ALTERNATIVE MEDICINE; AUSTRIA; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; DRUG UTILIZATION; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH INSURANCE; HOMEOPATHY; HUMAN; MASSAGE; MEDICAL LEAVE; OINTMENT; PRESCRIPTION; PRODUCTIVITY; REVIEW;

ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; AUSTRIA; CHILD; COMPLEMENTARY THERAPIES; COST-BENEFIT ANALYSIS; DERMATITIS, CONTACT; DRUG COSTS; ECZEMA; FEMALE; HEALTH CARE COSTS; HUMANS; HYPERSENSITIVITY; INSURANCE, HEALTH; MALE; MIDDLE AGED; SICK LEAVE; URTICARIA;

EID: 34347352226     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-007-0421-y     Document Type: Review

References (35)

1. European Lung Whitebook (2003) European Respiratory Society and the European Lung Foundation, Brüssel
2. van den Akker-van Marle ME, Bruil J, Detmar SB (2005) Evaluation of cost of disease: assessing the burden to society of asthma in children in the European Union. Allergy 60: 140-149
3. Szucs TD, Anderhub H, Rutishauser M (1999) The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 13: 281-286
4. Fineman SM (2002) The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol 88(4 Suppl 1): 2-7
5. Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F (2002) The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 147: 716-724
6. Crystal-Peters J, Crown WH, Getzel RD, Schutt D (2000) The Cost of Productivity Losses Associated With Allergic Rhinitis. Am J Manag Care 6: 373-378
7. Laforest L, Yin D, Kocevar VS, Pacheco Y, Dickson N, Gormand F, Van Ganse E (2004) Association between asthma control in children and loss of workdays by caregivers. Ann Allergy Asthma Immunol 93: 265-271
8. Weiss KB, Sullivan SD (2001) The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 107: 3-8
9. Birnbaum HG, Berger WE, Greenberg PE, Holland M, Auerbach R, Atkins KM, Wanke LA (2002) Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 109: 264-270
10. Miles S, Fordham R, Mills C, Valovirta E, Mugford M (2005) A framework for measuring costs to society of IgE-mediated food allergy. Allergy 60: 996-1003
11. Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D (2003) Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-year retrospective study. Eur Respir J 21: 116-122
12. Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH (2003) A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 111: 1212-1218
13. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M (2003) The economic impact of preschool asthma and wheeze. Eur Respir J 21: 1000-1006
14. Barnes PJ, Jonsson B, Klim JB (1996) The costs of asthma. Eur Respir J 9: 636-642
15. Sullivan SD, Weiss KB (2001) The health economics of asthma and rhinitis. II. Assessing the value of interventions. J Allergy Clin Immunol 107: 203-210
16. Serra-Batlles J, Plaza V, Merjón E, Comella A, Brugués J (1998) Costs of asthma according to the degree of severity. Eur Respir J 12: 1322-1326
17. Boston Consulting Group (1993) The cost of adult asthma in Canada. Princeton, NJ, Communications Media for Education
18. Plaza V, Serra-Batlles J, Ferrer M, Morrejón E (2000) Quality of Life and Economic Features in Elderly Asthmatics. Respiration 67: 65-70
19. IMCA - Indicators for monitoring Chronical Obstructive Pulmonary Disease (COPD) and asthma in the European Union, National Consistency: Austria. http://ec.europa.eu/health/ph_projects/2001/monitoring/ monitoring_project_2001_full_en.htm#10
20. Dorner T, Rieder A, Lawrence K, Kunze M (2006) Österreichischer Allergiebericht. Verein Altera mit Zukunft. Wien
21. Stadt Wien (Hrsg) (2001) Bereichsleitung für Gesundheitsplanung und Finanzmanagement Gesundheit in Wien. Wiener Gesundheits- und Sozialsurvey. Wien
22. Kammer für Arbeiter und Angestellte für Wien (2006) Die Bruttoeinkommen von Arbeitern und Angestellten im Jahr 2005. Neueste Daten des Hauptverbandes der österreichischen Sozialversicherungsträger, http://www.arbeiterkammer.at/www-192-IP-31456.html
23. Ungar WJ, Coyte PC and the Pharmacy Medication Monitoring Program Advisory Board (2000) Measuring Productivity Loss Days in Asthma Patients. Health Econ 9: 37-46
24. Dorner T, Müller KH, Schmidl H, Freidl W, Stronegger WJ, Lawrence K, Kunze M, Rieder A (2007) Subjective health and impaired quality of life due to allergies in a representative population survey. Wien Med Wochenschr 157: 243-247
25. Pitt AD, Smith AF, Lindsell L, Voon LW, Rose PW, Bron AJ (2004) Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 11: 17-33
26. Kemp AS (1999) Atopic eczema: its social and financial costs. J Paediatr Child Health 35: 229-231
27. Richardson LP, Lozano P, Russo J, McCauley E, Bush T, Katon W (2006) Asthma Symptom Burden: Relationship to Asthma Severity and Anxiety and Depression Symptoms. Pediatrics 118: 1042-1051
28. Braman S (2006) The Global Burden of Asthma. Chest 130: 4-12
29. O'Connell EJ (2004) The burden of atopy and asthma in children. Allergy 59 (Suppl 78): 7-11
30. Thomas M, Sazunov V, Zhang Q, Yin D, Price D (2005) Asthma-Related Health Care Resource Use Among Asthmatic Children With and Without concommitant Allergic Rhinitis. Pediatrics 115: 129-134
31. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) Program (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478
32. Bayer P (2006) Jahrbuch der Gesundheitsstatistik 2005. Statistik Austria, Wien
33. Simonella L, Marks G, Sanderson K, Andrews G (2006) Cost-effectiveness of current and optimal treatment for adult asthma. Intern Med J 36: 244-250
34. Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJH, Pedersen SE, Bateman ED (2006) Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 61: 531-536
35. Schermer TR, Thoonen BR van den Born G, Akkermans RP, Grol RP, Folgering HT, van Weel C, van Schayk CP (2002) Randomized Controlled Economic Evaluation of Asthma Self-Management in Primary Health Care. Am J Respir Crit Med 166: 1062-1072